LSKA Liska Biometry Inc (GM)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

Commission File Number: 333-94265

FORM 12b-25

For Period Ended: September 30, 2007

 |_| Transition Report on Form 10-K |_| Transition Report on Form 10-Q
 |_| Transition Report on Form 20-F |_| Transition Report on Form N-SAR
 |_| Transition Report on Form 11-K

For the Transition Period Ended :________________________

Read attached instruction sheet before preparing form. Please print or
type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

If the notification related to a portion of the filing checked above, identify the item(s) to which the notification relates:

PART I
REGISTRANT INFORMATION

Full name of registrant: Liska Biometry, Inc.

Former name if applicable: ___________________________________________

Address of principal executive office (street and number): 100 Main Street, Suite 230

City, state and zip code: Dover, New Hampshire 03082

|X| (a) The reasons described in reasonable detail in Part III of this form
 could not be eliminated without unreasonable effort or expense.

|X| (b) The subject annual report, semi-annual report, transition report on
 Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be
 filed on or before the fifteenth calendar day following the
 prescribed due date; or the subject quarterly report or transition
 report on Form 10-Q or portion thereof will be filed on or before
 the fifth calendar day following the prescribed due date; and

 (c) The accountant's statement or other exhibit required by Rule
 12b-25(c)has been attached if applicable.

 PART III
 NARRATIVE

State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period.

The Company's Quarterly Report on Form 10-QSB for the quarterly period ended September 30, 2007 cannot be filed within the prescribed time period because the Company requires additional time for compilation and review to insure adequate disclosure of certain information required to be included in the Form 10-QSB. The Company's Quarterly Report on Form 10-QSB will be filed on or before the 5th calendar day following the prescribed due date.

PART IV
OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification:

Christopher J. LeClerc, President, (877) 77-LISKA

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s)

|_| Yes |X| No

Form 10-QSB for the quarterly period ended March 31, 2007 Form 10-QSB for the quarterly period ended June 30, 2007

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

|_| Yes |X| No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reason why a reasonable estimate of the results cannot be made.

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date: November 15, 2007 By: /s/ Christopher J. LeClerc
 --------------------- -----------------------------------------
 Christopher J. LeClerc
 President and Chief Financial Officer

Liska Biometry (GM) (USOTC:LSKA)
Historical Stock Chart
From Dec 2024 to Jan 2025

Liska Biometry (GM) (USOTC:LSKA)
Historical Stock Chart
From Jan 2024 to Jan 2025